The Clinical Observation Of The Effect On"Fugongtongrufang"to Prophylactic Treatment Of Postpartum Lochiorrhea

Objective:To discuss the efficacy of using "fugongtongrufang" to prophylactic treatment on postpartum lochiorrhea, While observing its effects on lactation, For the clinical development of a safe and convenient and efficient way to provide a dedicated scientific clinical evidence.Method:80 cases of maternal hospital delivery which meet the inclusion criteria were used Single-blind, randomized method,and divided into the study group and the control group, separately give "Fugongtongrufang" and "chanfukang" particles to treat one treatment course(10 days), carries on the curative effect appraisal after the one treatment course. To observe around two groups of total curative effects, including lochia score after treatment changes, situation of Uterus descent after medication 3 days, situation of Uterine involution after medication 10 days, comparison the two groups before and after treatment changes in blood rheology, situation of lactation and the breast filling after medication 3 days and 10 days, etc. At the same time, we observe the blood routine, urine routine, liver and kidney function, ECG and other safety indicators.Results:After medication 3 days and 10 days,the lochia score in the study group was significantly better than the control group (P<0.05). The situation of Uterus descent in the study group was significantly better than the control group after medication 3 days (P<0.05). There was no significant difference between the study group and the control group in situation of Uterine involution after medication 10 days (P>0.05). There was no significant difference between two groups in whole blood reduced viscosity(low-cut, high-cut), fibrinogen, erythrocyte aggregation index after medication 3 days (P>0.05).But the two groups were Significant difference in plasma viscosity after medication 3 days (P< 0.05). After medication 10 days, the study group was significantly better than the control group in whole blood reduced viscosity(low-cut, high-cut), fibrinogen, erythrocyte aggregation index, plasma viscosity (P<0.05). After medication 10 days, both the study group and the control group were significantly better than before treatment in whole blood reduced viscosity(low-cut, high-cut), fibrinogen,erythrocyte aggregation index, plasma viscosity (P<0.05). The situation of lactation in the study group was significantly better than the control group after medication 3 days and 10 days (P<0.05). The breast filling in the study group was significantly better than the control group after medication 3 days and 10 days (P< 0.05). The course of medication safety indicators were normal.Conclusion:The "Fugongtongrufang" could effectively prevent and treat the postpartum Lochiorrhea, meanwhile, it could significantly increase the amount of postpartum lactation. The "Fugongtongrufang" could improve the situation postpartum lack of lactation and breastfeeding rates. Through clinical observation, the "fugongtongrufang" had good safety.